
### [MONDO:0018609](http://purl.obolibrary.org/obo/MONDO_0018609)
**Label:** syndromic hereditary optic neuropathy

**Subclasses:** [MONDO:0018105](http://purl.obolibrary.org/obo/MONDO_0018105) (Wolfram syndrome), [MONDO:0010714](http://purl.obolibrary.org/obo/MONDO_0010714) (Pelizaeus-Merzbacher disease), [MONDO:0009263](http://purl.obolibrary.org/obo/MONDO_0009263) (GAPO syndrome), [MONDO:0018550](http://purl.obolibrary.org/obo/MONDO_0018550) (spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder), [MONDO:0009841](http://purl.obolibrary.org/obo/MONDO_0009841) (PEHO syndrome), [MONDO:0010699](http://purl.obolibrary.org/obo/MONDO_0010699) (Charcot-Marie-tooth disease X-linked recessive 5), 

**Corr. equiv. classes:** [Orphanet:99014](http://www.orpha.net/ORDO/Orphanet_99014), [OMIM:222300](http://purl.obolibrary.org/obo/OMIM_222300), [OMIM:604928](http://purl.obolibrary.org/obo/OMIM_604928), [OMIM:311070](http://purl.obolibrary.org/obo/OMIM_311070), [OMIM:312080](http://purl.obolibrary.org/obo/OMIM_312080), [Orphanet:431320](http://www.orpha.net/ORDO/Orphanet_431320), [OMIM:213900](http://purl.obolibrary.org/obo/OMIM_213900), [OMIM:260565](http://purl.obolibrary.org/obo/OMIM_260565), [Orphanet:2067](http://www.orpha.net/ORDO/Orphanet_2067), [OMIM:230740](http://purl.obolibrary.org/obo/OMIM_230740), [Orphanet:2836](http://www.orpha.net/ORDO/Orphanet_2836), [Orphanet:99807](http://www.orpha.net/ORDO/Orphanet_99807), [Orphanet:702](http://www.orpha.net/ORDO/Orphanet_702), [OMIM:598500](http://purl.obolibrary.org/obo/OMIM_598500), [Orphanet:3463](http://www.orpha.net/ORDO/Orphanet_3463), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 46.31%
- Thing 46.29%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 46.29%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 44.65%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 40.35%
- [HP:0000598](http://purl.obolibrary.org/obo/HP_0000598) (Abnormality of the ear) 39.06%
- [HP:0000077](http://purl.obolibrary.org/obo/HP_0000077) (Abnormality of the kidney) and [HP:0000648](http://purl.obolibrary.org/obo/HP_0000648) (Optic atrophy) 37.80%
- [HP:0000648](http://purl.obolibrary.org/obo/HP_0000648) (Optic atrophy) and [HP:0010935](http://purl.obolibrary.org/obo/HP_0010935) (Abnormality of the upper urinary tract) 37.43%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 37.25%
- [HP:0000159](http://purl.obolibrary.org/obo/HP_0000159) (Abnormality of the lip) and [HP:0000648](http://purl.obolibrary.org/obo/HP_0000648) (Optic atrophy) 36.27%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 30.89%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 23.85%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) 23.09%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) 20.24%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 20.11%


